IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.717
AS - Asia 4.979
EU - Europa 3.344
SA - Sud America 1.557
AF - Africa 115
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.541
SG - Singapore 2.047
CN - Cina 1.442
BR - Brasile 1.267
SE - Svezia 833
HK - Hong Kong 712
IT - Italia 547
RO - Romania 534
VN - Vietnam 409
ES - Italia 340
RU - Federazione Russa 280
DE - Germania 230
FI - Finlandia 139
AR - Argentina 129
GB - Regno Unito 112
CA - Canada 90
MX - Messico 71
PL - Polonia 68
IN - India 59
FR - Francia 56
ID - Indonesia 54
EC - Ecuador 53
ZA - Sudafrica 52
IE - Irlanda 48
BD - Bangladesh 46
NL - Olanda 44
AT - Austria 41
TR - Turchia 41
JP - Giappone 36
IQ - Iraq 29
PY - Paraguay 26
CO - Colombia 23
AU - Australia 21
PE - Perù 18
UA - Ucraina 18
MA - Marocco 16
CL - Cile 14
IR - Iran 13
VE - Venezuela 13
DZ - Algeria 12
LT - Lituania 10
PK - Pakistan 10
EG - Egitto 9
UY - Uruguay 9
AZ - Azerbaigian 8
BE - Belgio 8
IL - Israele 8
KE - Kenya 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
MY - Malesia 7
NP - Nepal 7
SA - Arabia Saudita 7
EU - Europa 6
PT - Portogallo 6
AL - Albania 5
JO - Giordania 5
TN - Tunisia 5
BO - Bolivia 4
GR - Grecia 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PH - Filippine 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
LV - Lettonia 3
RS - Serbia 3
AO - Angola 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
KR - Corea 2
NZ - Nuova Zelanda 2
PA - Panama 2
SC - Seychelles 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
MK - Macedonia 1
MR - Mauritania 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
Totale 15.741
Salva come PNG Salva come JPEG
Città #
Dallas 3.099
Singapore 855
Hong Kong 705
Ashburn 421
Shanghai 362
Valencia 303
Hefei 298
Lawrence 244
Princeton 244
Milan 243
Beijing 223
New York 180
Ho Chi Minh City 142
São Paulo 111
Hanoi 100
Munich 100
Los Angeles 92
Moscow 73
Boardman 70
Helsinki 69
Turku 59
Dublin 47
Warsaw 47
Brooklyn 43
Rio de Janeiro 37
Montreal 34
Orem 33
Santa Clara 33
Tokyo 31
Johannesburg 28
Stockholm 28
Poplar 27
Washington 27
Denver 26
Seattle 26
Atlanta 25
Rome 24
Belo Horizonte 23
The Dalles 23
Toronto 23
London 22
West Jordan 22
Da Nang 21
Ankara 20
Brasília 20
Curitiba 20
Mexico City 20
Nuremberg 20
Phoenix 20
Quito 20
Guangzhou 19
Chicago 18
Frankfurt am Main 17
Amsterdam 16
Vienna 16
Columbus 15
Haiphong 15
Lima 15
Dhaka 14
Guarulhos 14
Guayaquil 14
Houston 14
Boston 13
Buenos Aires 13
Can Tho 13
Chennai 13
Ninh Bình 13
Shenzhen 13
Asunción 12
Campinas 12
New Delhi 12
Bexley 11
Cape Town 11
Charlotte 11
Falkenstein 11
Goiânia 11
Lappeenranta 11
Manaus 11
Porto Alegre 11
Ribeirão Preto 11
São Bernardo do Campo 11
Betim 10
Biên Hòa 10
Salvador 10
San Francisco 10
Santo André 10
Sorocaba 10
Bauru 9
Bitonto 9
Fortaleza 9
Jakarta 9
Manchester 9
Philadelphia 9
Querétaro 9
Baghdad 8
Baku 8
Brussels 8
Cairo 8
Hangzhou 8
Itaquaquecetuba 8
Totale 9.365
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.361
11C-choline PET/CT and PSA kinetics 1.348
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 133
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 123
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 122
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 121
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 117
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 115
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 113
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 111
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 110
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 108
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 106
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 102
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 98
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 97
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 95
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 95
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 93
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 92
Hypoxia pathway: 18F-FAZA 90
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 90
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 90
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 89
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 89
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 89
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 87
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 86
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 85
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 83
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 83
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 82
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 81
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 80
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 80
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 80
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 80
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 79
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 77
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 76
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 75
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 75
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 73
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 73
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 73
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 73
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 72
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 71
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 70
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 69
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 69
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 69
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 69
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 68
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 68
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 68
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 67
Radiomics and artificial intelligence 64
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 63
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 62
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 62
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 62
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 59
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 58
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 58
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 57
Nuclear medicine in prostate cancer management 57
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 57
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 56
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 55
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 54
VALIDAZIONE TRAMITE LINFOADENECTOMIA PELVICA E RETROPERITONEALE DELLA ACCURATEZZA DELLA TC/PET CON 11CCOLINA NELLA DIAGNOSI DI METASTASI LINFONODALI IN PAZIENTI CON RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO DOPO PROSTATECTOMIA RADICALE 54
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 54
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 53
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 53
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 51
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 50
First evaluation of PET-based human bioDistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia 50
New Clinical Indications for18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented] 50
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 50
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 49
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 49
Diagnosis of local recurrence after radical prostatectomy 48
[18F]FDG-PET and [11C]Choline-PET uptake in different types of NSCLC: Comparison with histological and molecular data. 48
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 48
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 48
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 47
TC/PET CON [11C] COLINA PER LA RISTADIAZIONE DEI PAZIENTI AFFETTI DA RECIDIVA BIOCHIMICA DI NEOPLASIA PROSTATICA DOPO PROSTATECTOMIA RADICALE E DI NESSUNA EVIDENZA DI MALATTIA ALL IMAGING TRADIZIONALE 47
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 47
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 47
Combined Use of TBNA and EBUS-TBNA in the Preoperative Staging of Lung Cancer Patients 46
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 46
PET/MRI and prostate cancer 45
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 45
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 45
Imaging in evaluation of response to neo-adjuvant treatment 45
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 44
Totale 9.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 36 1 2 2 1 0 1
2021/2022222 1 11 1 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/20254.332 529 66 65 99 141 302 1.162 285 584 441 288 370
2025/20268.816 927 1.466 3.291 1.935 924 273 0 0 0 0 0 0
Totale 16.182